PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis.

Autor: Urias E; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA., Tedesco NR; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA., Burkholder DA; Division of Gastroenterology and Hepatology, Houston Methodist Hospital, Houston, Texas, USA., Moran IJ; Michigan State University College of Medicine, East Lansing, Michigan, USA., Miller MJ; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA., Jasty VSJ; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA., Patil S; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, USA., Zoellner S; Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, USA., Wijarnpreecha K; Department of Medicine, Division of Gastroenterology and Hepatology, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA., Chen VL; Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.

Publikováno v: Hepatology communications [Hepatol Commun] 2024 May 22; Vol. 8 (6). Date of Electronic Publication: 2024 May 22 (Print Publication: 2024).